GROWTH-HORMONE PATHWAY COMPARISON
Ipamorelin/CJC-1295, Tesamorelin, and Sermorelin all work through the growth-hormone axis—the brain-to-pituitary chain that decides how much growth hormone the body releases—but each is studied for a different research focus. Compare them side by side, then explore the one that fits your goal.
COMPARE THE PROFILES
Highlight one peptide to see its relative research emphasis across the three growth-hormone outcomes. Ratings reflect each compound's studied focus, not a guarantee of results.
Growth & Recovery
A 1:1 blend delivering the strongest, most sustained GH release of the three. Studied for building lean mass, accelerating recovery, and enhancing performance.
Metabolic & Visceral Fat
Specifically studied for deep abdominal (visceral) fat reduction. Targets harmful VAT while preserving lean muscle and supporting metabolic health.
Gentle & Balanced
The original growth-hormone-releasing peptide. It nudges the body to make its own growth hormone on its normal schedule rather than forcing a large spike, which is why it is studied for steady, long-term support—overall wellness, vitality, and hormonal balance.
WHY RESEARCHERS COMPARE THEM
Each peptide has distinct strengths—muscle, visceral fat, or gentle wellness—for a specific research goal.
They are not substitutes for one another. Researchers pick by the outcome being studied—muscle, deep abdominal fat, or steady baseline support.
All three act on the well-understood growth-hormone axis and each carries an Established research-maturity rating.
Ratings reflect each compound's studied research emphasis relative to the other two—not absolute effect sizes or a promise of results. All three are offered strictly for laboratory and research use. See each compound page for its full Evidence Snapshot and research findings.
